The Use of Circulating Tumor DNA in the Management of Cutaneous, Thoracic and Breast Malignancies

The Use of ctDNA in the management of thoracic malignancies: Current use and future directions

Thursday, March 23, 2023

2:32 PM – 2:47 PM

Location: Ballroom A

Presenter(s)

Maximilian Diehn, MD, PhD

Professor
Stanford University

Disclosure(s): AstraZeneca: Advisor (Ongoing), Research Grant (Ongoing); Bristol Myers Squibb: Speaker (Ongoing); CiberMed: Advisor (Ongoing), Ownership Interest (Ongoing); Foresight Diagnostics: Advisor (Ongoing), Ownership Interest (Ongoing); Genentech: Advisor (Ongoing), Research Grant (Ongoing); Gritstone Oncology: Advisor (Ongoing), Stocks (Ongoing); Illumina: Advisor (Ongoing); Novartis: Speaker (Ongoing); Varian Medical Systems: Research Grant (Ongoing)

Disclosure(s):

Maximilian Diehn, MD, PhD: AstraZeneca: Advisor (Ongoing), Research Grant (Ongoing); Bristol Myers Squibb: Speaker (Ongoing); CiberMed: Advisor (Ongoing), Ownership Interest (Ongoing); Foresight Diagnostics: Advisor (Ongoing), Ownership Interest (Ongoing); Genentech: Advisor (Ongoing), Research Grant (Ongoing); Gritstone Oncology: Advisor (Ongoing), Stocks (Ongoing); Illumina: Advisor (Ongoing); Novartis: Speaker (Ongoing); Varian Medical Systems: Research Grant (Ongoing)